Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Total Non-Current Liabilities (2020 - 2026)

MDxHealth has reported Total Non-Current Liabilities over the past 7 years, most recently at $139.5 million for Q1 2026.

  • For Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $139.5 million; the TTM value through Mar 2026 reached $139.5 million, changed N/A, while the annual FY2025 figure was $110.5 million, 10.71% up from the prior year.
  • Total Non-Current Liabilities was $139.5 million for Q1 2026 at MDxHealth, up from $110.5 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $139.5 million in Q1 2026 and bottomed at $91.5 million in Q4 2022.
  • The 5-year median for Total Non-Current Liabilities is $102.4 million (2023), against an average of $108.8 million.
  • Year-over-year, Total Non-Current Liabilities soared 679.68% in 2022 and then dropped 2.52% in 2024.
  • Over 5 years, Total Non-Current Liabilities stood at $91.5 million in 2022, then rose by 11.86% to $102.4 million in 2023, then fell by 2.52% to $99.8 million in 2024, then increased by 10.71% to $110.5 million in 2025, then grew by 26.21% to $139.5 million in 2026.
  • The last three reported values for Total Non-Current Liabilities were $139.5 million (Q1 2026), $110.5 million (Q4 2025), and $99.8 million (Q4 2024) per Business Quant data.